Story

CVS Outlook Raised to Positive by Moody's on Health Insurance Turnaround

ENTHMSVIIDZHZH-TWJAKOHI
Aug 7, 20262 min read
CVS Outlook Raised to Positive by Moody's on Health Insurance Turnaround
Text size
Background

Moody's Ratings has revised its outlook on CVS Health Corp. (NYSE:CVS) to positive from stable, signaling growing confidence in the company's financial trajectory. The ratings agency on Friday affirmed CVS's Baa3 senior unsecured notes, Ba1 junior subordinated notes, and Prime-3 commercial paper rating, pointing to a successful turnaround in its health insurance division.

Turnaround Efforts Drive Deleveraging

The outlook change is primarily driven by CVS's progress in deleveraging its balance sheet. Moody's noted that the company has effectively managed its health insurance business by pruning membership, adjusting pricing and benefit designs, and exiting the individual health insurance market.

These strategic moves have significantly improved the company's key credit metrics. Moody's estimates CVS's gross debt-to-EBITDA ratio stood at approximately 3.7x as of June 30, 2026. This marks a substantial reduction from a peak of 5.0x at the end of 2024 and 4.4x at year-end 2025.

Core Strengths and Lingering Risks

CVS's investment-grade Baa3 rating is underpinned by its substantial scale and market-leading positions across several key sectors. The company's strengths include:

Sample IUX Markets – In-articleAd
  • Dominance in pharmacy benefit management (PBM), retail pharmacy, and health insurance.
  • Favorable industry fundamentals, such as rising prescription drug utilization.
  • Improved performance in its retail pharmacy operations, driven by a new reimbursement model.

Despite the positive outlook, Moody's highlighted persistent risks. The company continues to face industry-wide challenges and potential volatility within its health insurance operations, particularly in the Medicare Advantage segment. Furthermore, regulatory uncertainty looms over its PBM business practices following recent legislative reforms.

Path to an Upgrade

A future ratings upgrade is possible if CVS can demonstrate sustained operational strength across its key business segments while adhering to disciplined financial policies, according to Moody's. The agency specified that maintaining a debt-to-EBITDA ratio below 4.0x would be a key consideration for an upgrade. For the 12 months ended June 30, 2026, CVS reported total revenues of $415 billion.

Read next

More on Stocks
Back to latest news

LATEST